Cyclacel Pharmaceuticals Inc.
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 16 institutions reported holding Cyclacel Pharmaceuticals Inc. in their 13F filings, up 4 from Q1 2024. 5 opened new positions and 1 sold out. The largest holders were Armistice Capital, LLC ($217K), UBS Group AG ($62K) and Point72 Asset Management ($25K). 2 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Cyclacel Pharmaceuticals Inc.
- CUSIP
- 23254L801
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $254K |
| Exits | 1 | $44K |
All 13F filers, Q1 2024 → Q2 2024: 190,236 shares bought and 21,520 shares sold, net +168,716 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 16 holders
| Armistice Capital, LLC | 0.01% | New | 134,000 | $217K |
| UBS Group AG | 0.00% | Add +685.5% | 37,979 | $62K |
| Point72 Asset Management | 0.00% | No change | 15,333 | $25K |
| Acadian Asset Management LLC | 0.00% | No change | 14,285 | $23K |
| Citadel Advisors | 0.00% | New | 12,255 | $20K |
| HRT Financial LP | 0.00% | New | 10,694 | $17K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -16.1% | 3,513 | $6K |
| McIlrath & Eck, LLC | 0.00% | No change | 832 | $1K |
| Activest Wealth Management | 0.00% | New | 133 | $215 |
| Osaic Holdings, Inc. | 0.00% | No change | 126 | $203 |
| Morgan Stanley | 0.00% | No change | 80 | $130 |
| Wells Fargo & Company | 0.00% | Reduce -17.5% | 33 | $53 |
| Signaturefd, LLC | 0.00% | No change | 20 | $32 |
| Harbour Investments, Inc. | 0.00% | No change | 13 | $21 |
| Bank of America Corp. | 0.00% | New | 10 | $16 |
| Qube Research & Technologies Ltd | 0.00% | No change | 3 | $5 |
"% of holder's portfolio" is CYCLACEL PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Cyclacel Pharmaceuticals Inc. the manager owns.